A drug approved to treat a severe form of asthma dramatically improved the health of people with rare chronic immune disorders called hypereosinophilic syndromes (HES) in whom other treatments were ineffective or intolerable.

The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in healthy volunteers. Scientists at NIAID developed the experimental vaccine.

Survivors of Ebola virus disease (EVD) in Liberia had a higher prevalence of certain health issues when compared to a control group of household and community members who did not have a history of EVD.

Among people with HIV in Latin America, those diagnosed with tuberculosis (TB) at an initial clinic visit were about twice as likely to die within 10 years as people not initially diagnosed with TB.

A new study finds vitamin D may be protective among asthmatic obese children living in urban environments with high indoor air pollution.

Racial and ethnic disparities in severe maternal morbidity—life-threatening maternal complications associated with childbirth—have persisted and increased at high rates among U.S. women.

New findings from a large, randomized clinical trial that compared two infection-control techniques are already being incorporated into practice within the network of U.S. community hospitals where the trial took place.

Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improves our understanding of how alcohol affects the brain.

New guidance for universal suicide risk screening in health care settings.

Pelvic Floor Disorders Linked to Mode of Delivery Among First-Time Moms